Clinical Trials

A Randomized Study to Prevent Lymphedema in Women Treated for Breast Cancer

Collection of Patient-Reported Symptoms and Performance Status via the Internet

A Randomized, Phase III Study of Standard Dosing versus Longer Dosing
Interval of Zoledronic Acid in Metastatic Cancer

A Phase II Trial of Preoperative Irinotean, Cisplatin and Radiation in Esophageal Cancer

Randomized Phase II Study of ECF-C, IC-C or FOLFOX-C in Metastatic Esophageal and GE Junction Cancer

A Phase III Trial of Irinotecan/5-FU/
Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum

A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer

Phase III Randomized Study of Sorafenib plus Doxorubicin versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Hcc)

CYTOGENETIC STUDIES IN ACUTE LEUKEMIA

A Randomized, Double-Blind, Placebo-Controlled Phase III Study of Early versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men with Prostate Cancer Metastatic to Bone

Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer

A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma

THE CALGB LEUKEMIA TISSUE BANK

Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain

A Randomized Double-Blind Placebo-Controlled Study of Oral Coenzyme Q10 to Relieve Self-Reported Cancer Treatment Related Fatigue in
Breast Cancer Patients

A Phase II Double-Blind Feasibility Study of Armodafinil for Brain Radiation-Induced Fatigue

(Breast Cancer Prevention)

Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR)

Tamoxifen and Exemestane Trial (TEXT)

A Phase III Trial Evaluating the Role of Exemestane Plus GnRH Analogue as Adjuvant Therapy for Premenopausal Women with Endocrine Responsive Breast Cancer

Ovarian function suppression + tamoxifen versus
Ovarian function suppression + exemestane

A Phase III Randomized Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion

A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer

A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4 cm) -IIIA Non-Small Cell Lung Cancer (NSCLC)

Phase III Randomized Study of Four Weeks High Dose IFN-α2b in Stage T2b No, T3a-bN0, T4a-b No, and T1-4, N1a, 2a (microscopic) Melanoma

An Intergroup Phase III Randomized Controlled Trial Comparing Melphalan, Prednisone and Thalidomide Versus Melphalan, Prednisone and Lenalidomide in Newly Diagnosed Myeloma Patients Who Are Not Candidates for High-Dose Therapy

The BeST Trial: A Randomized Phase II Study of VEGF, RAF kinase, and mTOR Combination Targeted Therapy (CTT) with Bevacizumab, Sorafenib and Temsirolimus in Advanced Renal Cell Carcinoma

Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide (Revlimid®) Alone and in Combination with Epoetin Alfa(Procrit®) in Subjects with Low- or Intermediate-1 Risk MDS and Symptomatic Anemia